News

Novo Nordisk Stock Plummets After Ozempic Maker’s Shock Cut to U.S. Outlook
Novo Nordisk stock fell after the drugmaker unexpectedly cuts its full-year guidance, citing lower sales expectations for its ...
Obesity drugmaker Novo Nordisk plunges as it cuts forecasts again
COPENHAGEN (Reuters) -Obesity drugmaker Novo Nordisk on Tuesday cut its full-year sales and operating profit forecasts for ...
Novo Nordisk Stock Tumbles 20% After Ozempic Maker’s Shock Cut to U.S. Outlook
The drugmaker unexpectedly cuts its full-year guidance, citing lower sales expectations for its blockbuster drugs Wegovy and ...
Devdiscourse11m
Novo Nordisk Faces Forecast Cut Amid Obesity Drug Competition
Novo Nordisk, known for its obesity drug Wegovy, announced a reduction in its full-year sales and operating profit forecasts.
Gruber Plastic Surgery: "Ozempic Makeovers" on the Rise: Dr. Meegan Gruber Addresses Post-Weight-Loss Skin Laxity With Awake Body Contouring
TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...